Public Sector Pension Investment Board Has $9.02 Million Position in National Vision Holdings, Inc. $EYE

Public Sector Pension Investment Board boosted its position in shares of National Vision Holdings, Inc. (NASDAQ:EYE) by 14.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 308,942 shares of the company’s stock after buying an additional 39,394 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.39% of National Vision worth $9,018,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. American Century Companies Inc. raised its position in shares of National Vision by 2,030.3% during the second quarter. American Century Companies Inc. now owns 3,495,751 shares of the company’s stock worth $80,437,000 after acquiring an additional 3,331,657 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in National Vision by 11.8% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,857,635 shares of the company’s stock worth $65,754,000 after purchasing an additional 301,584 shares during the period. Bank of America Corp DE raised its holdings in National Vision by 127.9% during the 2nd quarter. Bank of America Corp DE now owns 1,965,856 shares of the company’s stock worth $45,234,000 after purchasing an additional 1,103,213 shares during the last quarter. Emerald Advisers LLC raised its holdings in National Vision by 20.7% during the 2nd quarter. Emerald Advisers LLC now owns 1,621,925 shares of the company’s stock worth $37,320,000 after purchasing an additional 278,597 shares during the last quarter. Finally, Fiera Capital Corp acquired a new position in National Vision during the 2nd quarter valued at about $25,070,000.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on EYE. Weiss Ratings reiterated a “sell (d-)” rating on shares of National Vision in a research report on Thursday, January 22nd. Wall Street Zen cut shares of National Vision from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Barclays increased their price target on National Vision from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, November 18th. Zacks Research raised National Vision from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 20th. Finally, National Bank Financial set a $32.00 target price on National Vision in a research note on Tuesday, December 9th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $29.00.

National Vision Trading Up 0.8%

Shares of NASDAQ:EYE opened at $28.22 on Tuesday. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of -940.35, a PEG ratio of 1.61 and a beta of 1.39. National Vision Holdings, Inc. has a 12 month low of $10.45 and a 12 month high of $30.02. The company’s fifty day simple moving average is $27.61 and its 200 day simple moving average is $26.27. The company has a quick ratio of 0.32, a current ratio of 0.53 and a debt-to-equity ratio of 0.28.

About National Vision

National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.

Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.